LRRC2-AS1

Across TCGA pan-cancer cohorts, LRRC2-AS1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LRRC2-AS1 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher LRRC2-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LRRC2-AS1 expression acts as an unfavorable survival marker, although some lineages such as READ and BLCA show a favorable association.

READ, DLBC, and LGG are the cancer types where LRRC2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Quartile	All	0.719	0.293	<.001	89	view →
DLBC	DFS	Median	IV	0.412	1.000	.006	46	view →
LGG	OS	Tertile	All	0.709	0.853	<.001	42	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	36	view →
BLCA	OS	Quartile	III,IV	0.647	0.474	.006	34	view →
KICH	DFS	Median	III,IV	0.373	1.000	.009	22	view →
BRCA	DFS	Tertile	All	0.969	0.930	.004	16	view →
UCS	DFS	Median	II,III,IV	0.529	0.192	.008	12	view →
CHOL	OS	Quartile	III,IV	0.300	0.922	.038	9	view →
PRAD	OS	Quartile	All	0.960	0.995	.028	6	view →
KIRC	DFS	Median	II,III,IV	0.371	0.587	.043	4	view →
SKCM	DFS	Tertile	All	0.327	0.177	.021	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LRRC2-AS1–READ (OS)

Open the READ breakdown →